» Articles » PMID: 2460875

Addition of a Foreign Oligopeptide to the Major Capsid Protein of Poliovirus

Overview
Specialty Science
Date 1988 Nov 1
PMID 2460875
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Insertion mutants of type 3 poliovirus (Sabin strain) were constructed that encode additional amino acid sequences at the level of residue 100 of the capsid polypeptide VP1 within the neutralization site 1, corresponding to a loop on the capsid surface. The addition of a tri- or hexapeptide did not hamper virus viability. The antigenic pattern of insertion mutants was only modified locally: all mutants lost reactivity of neutralization site 1 with the corresponding monoclonal antibodies, while the reactivity of sites 2 and 3 was unaffected by the insertion. We have shown for one of the mutants--vFG68--that the antigenic specificity of the neutralization site 1 was replaced by a new one. Although vFG68 differs from its parental Sabin strain only by the addition of three amino acids within VP1, neutralizing antibodies specific for vFG68 were induced by the native virion as well as by the heat-denatured mutated virions. Our results demonstrate that an oligopeptide of three or six amino acids can lengthen VP1 at the level of antigenic site 1 without affecting virus multiplication and that this foreign peptide is exposed on the virion surface.

Citing Articles

Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71.

Tan X, Chong W, Lee V, Abdullah S, Jasni K, Suarni S Vaccines (Basel). 2023; 11(8).

PMID: 37631931 PMC: 10458053. DOI: 10.3390/vaccines11081363.


Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design.

Lyu K, Wang G, He Y, Han J, Ye Q, Qin C J Biol Chem. 2014; 290(6):3198-208.

PMID: 25492868 PMC: 4318995. DOI: 10.1074/jbc.M114.624536.


Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

Chapman N, Kim K, Tracy S, Jackson J, Hofling K, Leser J J Virol. 2000; 74(17):7952-62.

PMID: 10933703 PMC: 112326. DOI: 10.1128/jvi.74.17.7952-7962.2000.


Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.

Georgescu M, Balanant J, MacAdam A, Otelea D, Combiescu M, Combiescu A J Virol. 1997; 71(10):7758-68.

PMID: 9311861 PMC: 192128. DOI: 10.1128/JVI.71.10.7758-7768.1997.


A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.

Tardy-Panit M, Blondel B, Martin A, Tekaia F, Horaud F, Delpeyroux F J Virol. 1993; 67(8):4630-8.

PMID: 8392604 PMC: 237848. DOI: 10.1128/JVI.67.8.4630-4638.1993.


References
1.
Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S . Rapid evolution of RNA genomes. Science. 1982; 215(4540):1577-85. DOI: 10.1126/science.7041255. View

2.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

3.
Himuma Y, Katagiri S, Aikawa S . Immune responses to H particles of poliovirus. Virology. 1970; 40(3):773-6. DOI: 10.1016/0042-6822(70)90228-x. View

4.
Cann A, Stanway G, Hauptmann R, Minor P, Schild G, CLARKE L . Poliovirus type 3: molecular cloning of the genome and nucleotide sequence of the region encoding the protease and polymerase proteins. Nucleic Acids Res. 1983; 11(5):1267-81. PMC: 325795. DOI: 10.1093/nar/11.5.1267. View

5.
Burke K, Dunn G, Ferguson M, Minor P, Almond J . Antigen chimaeras of poliovirus as potential new vaccines. Nature. 1988; 332(6159):81-2. DOI: 10.1038/332081a0. View